On November 3, 2023, Jeffrey Albers, a director at Blueprint Medicines Corp (NASDAQ:BPMC), sold 10,000 shares of the company's stock.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles
Home » Director Jeffrey Albers Sells 10,000 Shares of Blueprint Medicines Corp